HIV/AIDS in Thailand: Factors that Make Differences
Anupong Chitwarakorn
Ministry of Publ. Hlth., Bangkok, Thailand

Multinational Business Responding to AIDS in the South Africa
Gavin Churchyard
Aurum Hlth. Res., Anglo American, Welkom, South Africa

The Uganda Experience in Scaling Up HIV/AIDS Treatment and Care
Alex Coutinho
The AIDS Support Org. (TASO), Kampala, Uganda

Greetings from the Program Committee Chair
David Ho
Aaron Diamond AIDS Res. Ctr., Rockefeller Univ., New York, NY, USA

Keynote Lecture
Ambassador Stephen H. Lewis
United Nations Special Envoy on HIV/AIDS in Africa

Scaling Up HIV Testing for a Global Response to HIV/AIDS
David Miller
World Hlth. Org., Geneva, Switzerland

Ninth Annual Bernard Fields Memorial Lecture: Cellular Factors and HIV Budding
Wesley Sundquist
Eccles Inst. of Human Genetics, Univ. of Utah, Salt Lake City,USA

Maternal and Infrant Treatment Strategies for Preventing Mother-to-Child HIV Transmission
Elaine Abrams
Harlem Hosp. Ctr., Columbia Univ, New York, NY USA

Mitochondrial Toxicity Resulting from the Treatment of Pregnant Women and Infants
Stephane Blanche
Hosp. Necker, Paris, France

HIV Capture and Transmission by Dendritic Cells
Anthony Cunningham
Westmead Millennium Inst., Ctr. for Virus Res., Sydney, Australia

HIV Assembly in, and Release from, Primary Macrophages
Mark Marsh
Univ. Coll, London, UK

Enhancement of HIV Infection by Activated Dendritic Cells Occurs via Trafficking through a CD81 Enriched Compartment
David McDonald
Univ. of Illinois, Chicago, USA

Disorders of Bone Mass and Bone Metabolism
Stefano Mora
Sci. Inst. H San Raffaele, Univ. of Milan, Italy

Psychiatric Co-morbidity in HIV-infected Youth
Sharon Nachman
Stony Brook Univ., NY, USA

Molecular Virology and Pathogenesis of Hepatitis C
Charles Rice
Rockefeller Univ., New York, NY, USA

HIV-1 Spread Between T Cells via a Virological Synapse
Quentin Sattentau
The Sir William Dunn Sch. of Pathology, Univ. of Oxford, UK

Dyslipidemia, Osteopenia, and Changes in Body Habitus in HIV-infected Women
Ellie Schoenbaum
Montefiore Med. Ctr., Bronx, NY, USA

How Close Are We to an Effective Microbicide?
Robin Shattock
St.George's Hosp. Med. Sch., London, UK

Peripheral Neuropathy Associated with HIV and ARV: Update on Diagnosis and Management
David Simpson
Mount Sinai Sch. of Med., New York, NY, USA

Challenges Involved in Eliciting Neutralizing Antibodies to HIV
Dennis Burton
The Scripps Res. Inst., La Jolla, CA, USA

Why an HIV-1 Vaccine Is Not Currently within Our Grasp
Ronald Desrosiers
Harvard Med. Sch., New England Primate Res. Ctr., Southborough, MA, USA

An Independent Analysis of the Effect of Race in VAX004
Dean Follmann
NIAID, NIH, DHHS, Bethesda, MD, USA

Antiviral Proteins Targeting Viral RNA Formation
Steve Goff
Columbia Univ. Coll. of Physicians and Surgeons, New York, NY, USA

HIV Vif: Deactivation of a Deadly Deaminase
Nathaniel Landau
The Salk Inst. for Biological Studies, La Jolla, CA, USA

HLA Imprinting: Implications for Selection of Vaccine Immunogens
Simon Mallal
Ctr. for Clin. Immunology and Biomed. Statistics, Royal Perth Hosp., Australia

HIV/AIDS in Jails and Prisons
Jim McAuley
Cook County Jail, Chicago, IL, USA

Men on the "Down Low": More Questions than Answers
Greg Millett
CDC, Atlanta, GA, USA

DNA Editing and Host Resistance Factors
Michael Neuberger
Med. Res. Council, Cambridge, UK

Efficacy of AIDSVAX B/E Vaccine in Injecting Drug Users
Punnee Pitisutithum
Mahidol University, Bangkok, Thailand and Bangkok Vaccine Evaluation Group

Regulation of APOBEC3G Function by Vif
Ann Sheehy
Kings Coll. London, UK

Host Factors Controlling Species-Specific Replication of Lentiviruses
Greg Towers
Columbia Univ. Coll. of Physicians and Surgeons, New York, NY, USA and Wohl Virion Ctr., Windeyer Inst. Univ. Coll. London, UK

Defensive Arts: Antiviral Defense by APOBEC3G
Didier Trono
Univ. of Geneva, Switzerland

HIV Vaccine Efficacy Trials:Lessons Learned and Future Directions
Susan Buchbinder
San Francisco Dept. of Publ. Hlth., CA,USA

Herpes Simplex and the Global Epidemiology of HIV
Connie Celum
Univ. of Washington, Seattle, USA

Important Interactions between Drug Resistance Mechanisms: Implications for Therapy
Lisa Demeter
Univ.of Rochester Sch.of Med.and Dent.,NY,USA

Propelling Future Advances in HIV/AIDS Therapeutics through Basic Discovery
Warner Greene
Gladstone Inst.of Virology and Immunology,Univ.of California,San Francisco,USA

The Future of Antiretroviral Therapy: What If There Is No Vaccine?
Robert T. Schooley
Univ. of Colorado Hlth. Sci. Ctr., Denver, USA

Tuberculosis and HIV: Is There a Scientific Basis for Hope?
Peter M. Small
Bill and Melinda Gates Fndn., Seattle, WA, USA and Stanford Univ. Med. Ctr., CA, USA

Interaction of HIV and Malaria
Richard Steketee
CDC, Atlanta, GA, USA

Host Genetics and Pharmacogenetics: Implications for Clinical Practice
Amalio Telenti
Ctr.Hosp.Univ.Vaudois,Lausanne,Switzerland

Considerations for dosing tenofovir DF with other nRTIs
Terrence Blaschke
Univ. Sch. Of Med., CA, USA

Charles Boucher
Univ. Hosp. Utrecht, The Netherlands

TDM of nelfinavir in pregnancy
David Burger
Univ. Med. Ctr. Nijmegen, The Netherlands

Gender Differences in Antiretroviral Pharmacokinetics and Pharmacodynamics
Courtney Fletcher
Univ. of Colorado Hlth. Sci. Ctr., Sch. of Pharmacy, Denver, USA

The use of statins with HAART
John Gerber
Univ. of Colorado Hlth. Sci. Ctr., Denver, USA